Aldometanib
Selleck Chemicals
SKU:E1323-5MG
Couldn't load pickup availability
Aldometanib is an activator linked to PI3K-Akt-mTOR Signaling and related pathway-oriented research. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to growth-factor signaling, survival control, and nutrient-sensing outputs in metabolism models.
The pathway annotation connects Aldometanib to PI3K-Akt-mTOR Signaling, supporting experiments that monitor growth-factor signaling, survival control, and nutrient-sensing outputs across biochemical, cellular, or phenotypic assay formats. This context is compatible with AKT/mTOR readouts, pathway-response, and viability assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Pathway perturbation studies connected to PI3K-Akt-mTOR Signaling
- Gain-of-function pathway-activation studies
- Phenotypic profiling in metabolism models
- Combination studies with orthogonal perturbagens
Overall, Aldometanib is well suited to pathway-oriented studies that need a defined compound input for PI3K-Akt-mTOR Signaling readouts in metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Pathways:
- PI3K-Akt-mTOR Signaling
- Research Area:
- Metabolism
- CAS No.:
- 2904601-67-6
- Molecular Weight:
- 593.46
- Formula:
- C₂₇H₄₃Cl₂N₂·I
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.